Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Advertisement

New national cancer drug fund in pipeline

However, finding the finance for that fund won’t be easy, the NCCP’s director warns.

Image: e-MagineArt.com via Creative Commons

A NEW NATIONAL budget for cancer drugs will be set up before the end of this year, according to a report in the Irish Medical News today.

The new fund has identified 11 drugs – which make up around 80 per cent of current expenditure on oncology medication – which will be funded through the demand-led scheme.

The move will see control for expensive adjuvant cancer therapies removed  from hospitals.

National Cancer Control Programme (NCCP) director Dr Susan O’Reilly said that negotiations on how the fund will operate are still going on between the NCCP, the HSE and the Primary Care Reimbursement Service. She also said that financing the drugs scheme would prove difficult “because there is no new money”.

Read more about the planned fund in Paul Mulholland’s report in the Irish Medical News >

Making a difference

A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.

Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

For the price of one cup of coffee each week you can make sure we can keep reliable, meaningful news open to everyone regardless of their ability to pay.

Read next:

COMMENTS (3)